Value Bridge — CARILION MEDICAL CENTER
Current $-165M → Target $-132M (+$32.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-164.5M
Current EBITDA
$-132.2M
Target EBITDA
+$32.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.3M
Payer Mix Optimization
$17.5M
Cost to Collect Reduction
$5.8M
Clean Claim Improvement
$4.4M
Volume & Rate Growth
$29.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-165M to $-132M. The highest-impact lever is Volume & Rate Growth at $11.7M probability-weighted.
IC talking point: "We see $32M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $355M in equity value creation."